An American company Eli Lilly in 1983 prepared two DNA sequences corresponding to A and B, chains of human insulin and inserted in plasmids of E, coli to produce insulin chains. Chains A and B were produced separately, extracted and combined by creating disulfide bonds to form human insulin.